Q30 Innovations
Q30 Innovations develops and sells the FDA-cleared Q-Collar, a non-invasive neck-worn device that reduces brain movement during head impacts for athletes, military, and tactical operators. The company generates one-time hardware revenue through DTC e-commerce, team sales, and US/Canada channels.
- Company typePrivate
- Founded2011
- HeadquartersWestport, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Q30 Innovations does
Q30 Innovations is a privately held research and development company founded circa 2011–2012, headquartered in Norwalk, Connecticut, that develops and commercializes the Q-Collar — a non-invasive, FDA-cleared Class 2 medical device worn around the neck that applies controlled pressure to the internal jugular veins to increase intracranial blood volume and reduce brain movement ("brain slosh") during head impacts. The company's product line includes the Q-Collar ($199) for athletes in contact sports (football, soccer, hockey, lacrosse), the Q-Collar Tactical ($249) for military and law enforcement operators, and the Q-Collar Sleeve ($19.99) accessory. The mechanism of action is protected by six issued US utility patents and one design patent, and is supported by more than 25 peer-reviewed clinical studies conducted over 10+ years at institutions including Cincinnati Children's Hospital, Boston Children's Hospital, NorthShore University HealthSystem, West Virginia University, Harvard, University of Toronto, and the Naval Medical Research Center.
The business operates a direct-to-consumer e-commerce channel through q30.com alongside team and institutional sales to professional leagues, collegiate athletic programs, and the US military, plus a Canadian subsidiary (Q30 Sports Canada, Inc.). Revenue is generated entirely through one-time hardware sales — there is no subscription component. Go-to-market is reinforced by an athlete ambassador program featuring active and retired professional athletes across the NFL, MLS, PLL, NHL and NWSL, event sponsorships including the Premier Lacrosse League (as exclusive Brain Injury Protection Partner since 2022) and the Best Ranger Competition, and federally funded military research contracts including a $2.8M US Army Medical Research award in October 2022 and $2.5M in additional federal funds highlighted in April 2024. The company has sold to a cumulative base of 50,000+ athletes since FDA clearance in February 2021 and ships to the US and Canada only.
Q30 Innovations firmographics
Firmographics- Name
- Q30 Innovations
- Legal name
- Q30 Innovations, LLC
- Website
- https://q30.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Q30 Innovations develops and sells the FDA-cleared Q-Collar, a non-invasive neck-worn device that reduces brain movement during head impacts for athletes, military, and tactical operators. The company generates one-time hardware revenue through DTC e-commerce, team sales, and US/Canada channels.
- Ownership category
- akta.pro rank
Q30 Innovations industry classification
Industry- Product category
- Brain Protection Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Safety Accessories & Wearables Retail (Neck Braces, Hydration, Earplugs) (CRAMANAL)
- akta.pro secondary industry
- Wearable Accessories & Bands (straps, chargers, cases) (CRACAIAK)
Keywords
Where Q30 Innovations is headquartered
LocationHeadquarters
- HQ city
- Westport
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Q30 Innovations business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations
Revenue model
- Q-Collar Hardware Sales: One-time hardware purchase of Q-Collar devices. Q-Collar at $199, Q-Collar Tactical at $249, Q-Collar Sleeve accessories at $19.99. No subscription or recurring revenue model. Revenue generated from direct consumer and team/institutional sales.
- Team/Institutional Sales: Bulk purchases by sports teams, collegiate programs, and military organizations. Includes partnerships with universities (Maryland, Baylor, Michigan State) and military (US Army contracts).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Q-Collar (Standard) - $199.00 |
| Unit Pricing | Pay-as-you-go | Q-Collar Tactical - $249.00 |
| Unit Pricing | Pay-as-you-go | Q-Collar Sleeve - $19.99 |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels8 records
Q30 Innovations product offering
Product offeringCore offering
Q30 Innovations designs, manufactures, and sells the Q-Collar, an FDA-cleared Class 2 medical device worn around the neck that applies mild internal jugular vein compression to increase intracranial blood volume and reduce brain movement ("brain slosh") during impacts. The company offers a standard Q-Collar for athletes ($199), a Tactical version for military/tactical operators ($249), and color-customizable Q-Collar Sleeve accessories ($19.99), sold via direct-to-consumer e-commerce, team sales programs, retail partners, and government procurement.
Product overview
Q30 Innovations offers a product line centered on the Q-Collar family of brain protection devices. The core offering is the Q-Collar ($199) for athletes, alongside the Q-Collar Tactical ($249) for military operators, with the Q-Collar Sleeve ($19.99) as a color-customizable accessory. All devices apply mild internal jugular vein compression to increase intracranial blood volume, reducing brain movement upon impact to help protect against traumatic brain injury. The products are FDA-cleared Class 2 medical devices backed by over 25 independent clinical studies.
Differentiator
Problem solved
Functional benefit
Brands
- Q-Collar: FDA-cleared brain protection device worn around the neck to help reduce brain movement during impacts
- Q-Collar Tactical
- Q-Collar Sleeve
Products and services
- Q-Collar FDA-cleared Class 2 medical device worn around the neck that applies mild internal jugular vein compression to increase blood volume in the head, reducing brain movement during impacts. Designed for athletes aged 13+ in contact sports including football, soccer, hockey, and lacrosse. Priced at $199 with multiple colors and sizes.
- Q-Collar Tactical Variant of the Q-Collar designed specifically for military and tactical operators, providing additional brain protection against blast waves and blunt force head impacts in operational and training environments. Priced at $249 with enhanced durability.
- Q-Collar Sleeve Customizable protective sleeve that fits over the Q-Collar, available in 15 colors to match team uniforms and personal preferences. Priced at $19.99 with bundle discounts available.
Quantifiable outcome
- 66% reduction in likelihood of brain damage from contact sports over a season of play (clinical trial result)
- +3 more outcomes
Companies that use Q30 Innovations
Customer profileNamed customers20 records
Segments4 records
Ideal customer profiles3 records
Q30 Innovations technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Q30 Innovations partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and major.
- University of MarylandcoreOfficial collegiate partnership providing student athletes access to Q-Collar. Includes NIL partnerships and research collaboration.
- Baylor UniversitycoreOfficial collegiate partnership with Q30 Innovations providing student athletes access to Q-Collar for brain protection.
- Michigan State UniversitycoreOfficial collegiate partnership providing student athletes access to Q-Collar for brain protection.
- Best Ranger CompetitionmajorQ30 and Best Ranger Competition partnership to help safeguard Army Rangers with Q-Collars during the 40th anniversary competition at Fort Moore, Georgia. Q-Collars worn to reduce TBI risk during high-impact activities.
- US Army Medical Research and Development Commandmajor$2.8 million contract awarded by USAMRDC to evaluate safety, effectiveness, and field suitability of Q-Collar to help prevent or reduce TBI from blunt force and blast waves in soldiers.
- Premier Lacrosse LeaguecoreExclusive Brain Injury Protection Partner of PLL since 2022. Q30 equips athletes across all eight PLL teams with Q-Collars. Partnership includes sponsorship of PLL College Draft (presented by Q-Collar) and Inside Lacrosse High School Rankings.
- Cincinnati Children's Hospital Medical CentercoreMultiple clinical studies conducted including Human Performance Study, Hockey Study (2014), Football Study (2015-2017), Soccer Study (2016), and tolerability/wearability studies with NFL and CFL players.
- NorthShore University HealthSystemcoreDr. Julian Bailes leads research including swine impact safety study and small animal hearing loss studies. Dr. Bailes serves as Q30 Chief Medical Advisor.
- Boston Children's HospitalcoreCollaborated on large animal effectiveness study (swine impact model) and research validation for Q-Collar technology.
- Harvard UniversitycoreResearch collaboration on closed head rotational head impact protocol in swine model.
- West Virginia UniversitycorePre-clinical and clinical research partner for Q-Collar studies.
- University of TorontocoreDr. Joseph Fisher (inventor, professor, Chief Scientist at Thornhill Research) contributed to Q-Collar development and research.
- Naval Medical Research Center at Walter Reed HospitalcoreInvestigated whether IJV compression could provide protection against blast-induced TBI in military context.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Q30 Innovations competitors and assessment
Company assessmentDirect peers
- Unequal Technologies: Developer of protective sports gear using impact-absorbing materials for head, chest, and body protection. Directly comparable to Q30 as a sports protective equipment company serving athletes across multiple contact sports.
- GuardLab: Mouthguard company with embedded sensors for impact tracking and concussion prevention in contact sports. Comparable to Q30 as a head-impact protection company with presence in NFL, NHL, and college sports markets.
- Battle Sports Science: Sports protective equipment company specializing in mouthguards, gloves, and pads for football, lacrosse, and hockey. Comparable to Q30 in targeting amateur and professional athletes across the same contact sports categories.
- VICIS: Football helmet manufacturer using novel impact-mitigation technology to reduce brain injury. Comparable to Q30 as a head-impact protection company focused on reducing concussion risk in contact sports with FDA/state-of-the-art positioning.
Broad incumbents
- Riddell: Largest US football helmet manufacturer with deep league relationships and broad retail distribution. Comparable to Q30 as an established player in football head protection, but operates at much broader scale as a traditional helmet incumbent.
- Schutt Sports: Major football helmet and protective equipment manufacturer serving high school, collegiate, and professional markets. Comparable to Q30 in serving the same football head protection category but with broader product portfolio and incumbency.
- Xenith: Football helmet manufacturer known for novel impact attenuation technology and broad NCAA/NFL distribution. Comparable to Q30 as a head protection company targeting the same football market with complementary rather than directly competing technology.
Emerging players
- Prevent Biometrics: Developer of sensor-equipped mouthguards for real-time head impact monitoring and concussion detection. Comparable to Q30 in the head-impact protection space but differentiated through diagnostic/monitoring rather than injury mitigation.
- Orpyx Medical Technologies: Medical wearable company with FDA-cleared sensor-embedded insoles for diabetic neuropathy and pressure monitoring. Comparable to Q30 as a regulated medical device wearable company targeting specific clinical indications.
Others
- ImPACT Applications: Provider of FDA-cleared neurocognitive testing tools for concussion assessment and management. Comparable to Q30 as a TBI-focused company in the broader brain injury ecosystem, but focused on assessment rather than protection.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Q30 Innovations social profiles
Digital presenceQ30 Innovations compliance and trust
Trust signalCompliance2 records
Q30 Innovations financial estimates
Financial estimateRevenue estimate
Valuation estimate
Q30 Innovations leadership team
Management profileNumber of profiles
Profiles8 records
Q30 Innovations subsidiaries and ownership
Company hierarchySubsidiaries1 record
Q30 Innovations funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Q30 Innovations M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Q30 Innovations
What does Q30 Innovations do?
Q30 Innovations designs, manufactures, and sells the Q-Collar, an FDA-cleared Class 2 medical device worn around the neck that applies mild internal jugular vein compression to increase intracranial blood volume and reduce brain movement ("brain slosh") during impacts. The company offers a standard Q-Collar for athletes ($199), a Tactical version for military/tactical operators ($249), and color-customizable Q-Collar Sleeve accessories ($19.99), sold via direct-to-consumer e-commerce, team sales programs, retail partners, and government procurement.
Is Q30 Innovations a public or private company?
Q30 Innovations is a private company. It is classified as venture growth investor backed and is currently operating.
When was Q30 Innovations founded?
Q30 Innovations was founded in 2011. It employs 11 to 50 people.
Where is Q30 Innovations based?
Q30 Innovations is headquartered in Westport, United States, in the North America region.
How does Q30 Innovations make money?
Two revenue lines are on record. Q-Collar Hardware Sales are the primary driver. The others are team/Institutional Sales.
Who are Q30 Innovations's main competitors?
Direct peers on record are Unequal Technologies, GuardLab, Battle Sports Science and VICIS. Broad incumbents are Riddell, Schutt Sports and Xenith. Emerging players are Prevent Biometrics and Orpyx Medical Technologies. ImPACT Applications is listed as an others.
Does Q30 Innovations have an API?
No public API is recorded for Q30 Innovations.
What industry is Q30 Innovations in?
Q30 Innovations's product category is Brain Protection Medical Devices. Its primary akta.pro industry code is CRAMANAL, Safety Accessories & Wearables Retail (Neck Braces, Hydration, Earplugs), with a secondary code of CRACAIAK, Wearable Accessories & Bands (straps, chargers, cases). Its NAICS code is 339112 and its SIC code is 3841.